Even if clinical trials suggest tolerability, the real-world risk profile changes when: the source and purity of the peptide are uncertain, its used in different routes than studied, its used in stacked protocols with other drugs, its used in populations the trials didnt represent
It is knowing which patient needs a GLP-1 and which one needs a workup, how to titrate through the nausea window without losing the patient, how to protect lean mass during rapid loss, how to screen for the contraindications that matter, and how to tell a patient honestly what an adjunct will and will not do for them
Diagnostic Dose (Provocative Testing): In endocrinology practice, sermorelin (GHRH 1-29) can be used as a diagnostic agent to test pituitary GH reserve
They can also help expectant mothers build up their supply of Vitamin B9 (Folate) to reduce the risk of neural tube defects like spina bifida
Most clinicians cycle patients off the peptides for equivalent periods after a treatment course to allow the bodys signaling to normalize